Ausgabe 2/2013
Health Policy and Cardiac Electrophysiology
Inhalt (12 Artikel)
Foreword: health policy and cardiac electrophysiology
Mark A. Hlatky, Matthew Reynolds, Mintu Turakhia
FDA regulation of cardiovascular devices and opportunities for improvement
Sanket S. Dhruva, Rita F. Redberg
Health care policy and regulatory implications on medical device innovations: a cardiac rhythm medical device industry perspective
Arjun Sharma, Anthony Blank, Parashar Patel, Kenneth Stein
US Health Care Policy and Reform: implications for cardiac electrophysiology
Mintu P. Turakhia, Aditya J. Ullal
The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis
Attila Roka, Mark H. Schoenfeld
Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation
Roger A. Winkle, R. Hardwin Mead, Gregory Engel, Melissa H. Kong, Rob A. Patrawala
Prediction and prevention of sudden death in young populations: the role of ECG screening
Kevin R. Dougherty, Richard A. Friedman, Mark S. Link, N. A. Mark Estes III
Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy
Kerry E. Joyce, Stephen Lord, Daniel D. Matlock, Janet M. McComb, Richard Thomson